Ninety One (UK)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-21,967
Closed -$3.78M 308
2017
Q2
$3.78M Buy
21,967
+20,108
+1,082% +$3.27M 0.02% 232
2017
Q1
$305K Sell
1,859
-654
-26% -$109K ﹤0.01% 291
2016
Q4
$367K Hold
2,513
﹤0.01% 289
2016
Q3
$419K Buy
2,513
+220
+10% +$37.2K ﹤0.01% 283
2016
Q2
$349K Buy
2,293
+291
+15% +$45.2K ﹤0.01% 274
2016
Q1
$300K Buy
+2,002
New +$297K ﹤0.01% 284

Other funds holding AMGN

Ninety One (UK)'s AMGN Position: Q3 2017 in Review

Ninety One (UK) sold out of Amgen (AMGN) in Q3 2017, closing a stake of 21,967 shares — an estimated $3.78M sold.

Ninety One (UK) first reported a position in AMGN in Q1 2016 and held it in 6 quarters. The position peaked at $3.78M in Q2 2017. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Ninety One (UK) reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Ninety One (UK) sold 21,967 Amgen shares in Q3 2017, an estimated $3.78M.
  • Ninety One (UK) first reported a position in Amgen in Q1 2016 and held it in 6 quarters.
  • Ninety One (UK)'s Amgen position peaked at $3.78M in Q2 2017.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Ninety One (UK)'s 13F filing for Q3 2017, filed 13 Nov 2017.